<DOC>
	<DOCNO>NCT00311116</DOCNO>
	<brief_summary>The primary objective determine whether child undergo doxorubicin-containing chemotherapy , topical vitamin E , compare placebo , decrease objective measurement oral mucositis .</brief_summary>
	<brief_title>Vitamin E Prevent Mucositis Children With Cancer</brief_title>
	<detailed_description>Oral mucositis common consequence chemotherapy important sequela cancer therapy painful affect quality life , may lead hospitalization hydration pain control , provide portal entry oral microflora . In addition , oral mucositis become major dose-limiting toxicity consequently , may limit delivery anti-cancer therapy . Despite frequency mucositis , feasible therapy proven successful prevent mucositis child . Vitamin E fat-soluble essential vitamin may protect doxorubicin-induced oral mucositis anti-oxidant property . In study , examine efficacy topical vitamin E prophylaxis chemotherapy-induced mucositis novel methodology appropriate study rare condition , namely combine N-of-1 trial use Bayesian meta-analysis . The primary outcome objective mucositis score measure day 7 , 10 , 14 17 . Secondary outcome include daily pain swallow visual analogue scale score , World Health Organization mucositis score collect day 5 20 . Comparisons : Objective subjective mucositis score compare cycle associate topical vitamin E versus cycle associate placebo administration . We use repeated measure analysis within Bayesian framework order conduct comparison .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<criteria>diagnosis cancer treat Hospital Sick Children , Toronto , Canada plan chemotherapy include least two identical course doxorubicincontaining chemotherapy dose doxorubicin least 60 mg/m2 per course least 6 year age less 18 year live Greater Toronto area allergy vitamin E placebo ingredient child unable comply topical vitamin E application cild receive head neck irradiation</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Vitamin E</keyword>
	<keyword>Cancer</keyword>
	<keyword>pediatrics</keyword>
	<keyword>supportive care</keyword>
	<keyword>oral mucositis</keyword>
	<keyword>Bayesian analysis</keyword>
	<keyword>N-of-1 trial</keyword>
	<keyword>prophylaxis</keyword>
</DOC>